Skip to content

A Clinical Study to Evaluate the Efficacy, Safety and Consumer Perception of a Moisturizing Product

A Clinical Study to Evaluate the Efficacy, Safety and Consumer Perception of a Moisturizing Product - A Clinical Study to Evaluate the Efficacy, Safety and Consumer Perception of a Moisturizing Product

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053216
Enrollment
30
Registered
2023-12-26
Start date
2023-12-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sensitive skin

Interventions

Apply the test material to the lower leg once a day for 4 weeks.

Sponsors

LION CORPORATION
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ?18-65 years old females those who have extremely dry skin and pruritus, or previous experience barrier damage, eczema or atopic dermatitis ?Those who have a VAS score between 2.5 cm and 7.4 cm after using the wash-out product for 7 days. ?Those who have a redness score of 1 or more and less than 3 in visual assessment by dermatologist. ?Those who fully understand the objective and contents of the study and voluntarily decide to participate. ?Those who understand the possible adverse reactions and sign the informed consent form. ?Those who do not have acute or chronic diseases including skin diseases which can affect the study (severe infections or eczematous skin diseases including atopic dermatitis). ?Those who are available for observations throughout the entire study. ?Those who are able to visit the laboratory according to set schedules and follow the study instructions.

Exclusion criteria

Exclusion criteria: ?Those who have experienced allergic reactions to cosmetics or have sensitive and hyper-sensitive skin. ?Those who are pregnant, breast feeding or planning pregnancy. ?Those who have prominent nutrition disorder. ?Those who are drug addict or alcoholic. ?Those who have moles, acne, tattoo, scars, red spots, telangiectasis, burns, etc. in the test site. ?Those who have participated in the same clinical evaluation within 6 months. ?Those who have been using steroid or retinoid for treatment of skin disease more than 1 month or are taking medicines which can affect the skin (e.g.,anti-histamines, immunosuppressants). ?Those who have used cosmetics and pharmaceuticals with similar efficacy within 3 months before starting the study. ?Those who have undergone any dermatologic procedures within 6 months. ?Those who are participating in the same clinical study/studies conducted by Ellead or other clinical institution on the same body site/sites. ?Those who have been judged by the research director to be unsuitable for enrollment in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Evaluation of itch(VAS method), stratum corneum water content, TEWL, redness(dermatological assessment) before the application of the test material and immediately after application of the test product - after 4 weeks of continuous use.

Countries

Asia(except Japan)

Contacts

Public ContactAKINORI INOUE

LION CORPORATION Global Development Center

ino-aki@lion.co.jp08012731828

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026